The global emergence of drug-resistant bacteria leads to the loss of efficacy of our antibiotics arsenal and severely limits the success of currently […]

The present invention arises from a formulation study in order to define the best excipients including buffer, surfactant, sugar and amino acid to […]

Antimicrobial resistance is a global problem, rendering conventional treatments less effective and requiring innovative strategies to combat this […]

Type 1 conventional dendritic cells (cDC1s) and plasmacytoid dendritic cells (pDCs) are thought to be critical for anti-tumor or antiviral immunity. […]

The present invention relates to the field of adjuvant and vaccination. In the present study, the inventors investigate whether P1, in addition to […]

Macrophages (MØ) are critical for the detection and clearance of pathogens and yet also serve as replication niches for multiple infectious agents. […]

Alphaviruses, such as chikungunya virus (CHIKV), are mosquito-borne viruses that represent a significant threat to human health due to the current […]

The present invention relates to the treatment of infectious diseases. In this study, the inventors identified the potential protective mechanisms […]

The present invention relates to a hepcidin antagonist for use in the treatment of inflammatory diseases. TLR4-dependant intestinal hepcidin induces […]

Voltage-dependent calcium channels (Cav1) contribute to T-cell activation. The inventors previously showed that Th2 cells co-express Cav1.2 and Cav1.3 […]